case_images: PMC8128506_01
case_images: Facial transformation in a 40-year-old male-to-female transgender patient who received onabotulinumtoxinA and dermal fillers to feminize the face. Photographs were taken 2 months post-treatment. Patient images provided by Alexander Rivkin, MD.
case_images: CCID-14-513-g0002.jpg
case_images: PMC8128506_01_CCID-14-513-g0002.jpg
case_images: f0002
case_images: Facial transformation in a 40-year-old male-to-female transgender patient (Figure 2).
case_images: PMC8128506_02
case_images: Full-face transition of a 25-year-old male-to-female transgender patient who received onabotulinumtoxinA and dermal fillers to feminize the face. (A) Colored dots and arrows indicate injection points with corresponding concentrations of onabotulinumtoxinA or filler injected. (B) The patient before (left) and 3 months after (right) treatment. Patient images provided by Vincent Wong, MD.
case_images: CCID-14-513-g0003.jpg
case_images: PMC8128506_02_CCID-14-513-g0003.jpg
case_images: f0003
case_images: Full-face transition in a 25-year-old male-to-female transgender patient (Figure 3).
case_images: PMC8128506_03
case_images: Masculinization of the jawline with repeated VYC-20L injections in a 42-year-old female-to-male transgender patient. (A) Colored dots and arrows indicate injection points with corresponding concentrations of filler injected. (B) The patient before (left) and 4 months after (right) treatment. Patient images provided by Koenraad De Boulle, MD.
case_images: CCID-14-513-g0004.jpg
case_images: PMC8128506_03_CCID-14-513-g0004.jpg
case_images: f0004
case_images: Masculinization of the jawline in a 42-year-old female-to-male transgender patient (Figure 4).
case_images: PMC8128506_04
case_images: Female-to-male jawline and chin enhancement in a 19-year-old patient who received VYC-25L. (A) Colored dots and arrows indicate injection sites with corresponding concentrations of filler injected. (B) The patient before (top) and immediately after (bottom) treatment. Photographs were taken immediately following treatment. Patient images provided by Vincent Wong, MD.
case_images: CCID-14-513-g0005.jpg
case_images: PMC8128506_04_CCID-14-513-g0005.jpg
case_images: f0005
case_images: Female-to-male jawline and chin enhancement in a 19-year-old patient (Figure 5).
case_images: Feminization of the eyebrow using onabotulinumtoxinA in a patient in his late 20s. The patient before (left) and 2 weeks after (right) treatment. Patient images provided by Terrence Keaney, MD.
case_images: CCID-14-513-g0006.jpg
case_images: PMC8128506_04_CCID-14-513-g0006.jpg
case_images: f0006
case_images: Feminization of the eyebrow using onabotulinumtoxinA in a patient in his late 20s (Figure 6).
case_images: Feminization of the lips using HYC-24L in a patient in his early 60s. The patient before (left) and 2 weeks after (right) treatment. Patient images provided by Terrence Keaney, MD.
case_images: CCID-14-513-g0007.jpg
case_images: PMC8128506_04_CCID-14-513-g0007.jpg
case_images: f0007
case_images: Feminization of the lips using HYC-24L in a patient in his early 60s (Figure 7).